Reduction in Neuroleptic-Induced Movement Disorders After a Switch to Quetiapine in Patients With Schizophrenia
- 1 February 2008
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Clinical Psychopharmacology
- Vol. 28 (1), 69-73
- https://doi.org/10.1097/jcp.0b013e318160864f
Abstract
Persistent neuroleptic-induced movement disorders limit effective pharmacological management of psychotic disorders. Although antipsychotic switching is a common strategy for managing extrapyramidal side effects (EPSs), there is insufficient empirical support to guide the clinician. We designed the present study to examine whether patients with preexisting EPS switched to quetiapine would show greater reduction in EPS compared with control patients.Twenty-two patients with schizophrenia meeting clinical criteria for tardive dyskinesia or coexisting parkinsonism were randomized either to switch from their current antipsychotic to quetiapine (n = 13) or to remain on their current treatment (n = 9). A battery of standard clinical assessments for EPS along with electromechanical instrumental measures was administered before randomization and again 1 and 3 months postrandomization.We observed significant reduction in parkinsonism (P < 0.001) and akathisia (P = 0.02) based on clinical assessments and dyskinesia (P < 0.05) based on instrumental assessment for the quetiapine group. Subjects remaining on current treatment exhibited an increase in rigidity (P < 0.05) based on instrumental measures.These findings support the switching to quetiapine in the management of preexisting neuroleptic-induced extrapyramidal side effects.This publication has 23 references indexed in Scilit:
- Improvement Without Impairment: A Review of Clinical Data for Quetiapine in the Treatment of SchizophreniaJournal of Clinical Psychopharmacology, 2003
- Quetiapine-induced improvement of tardive dyskinesia in three patients with schizophreniaInternational Clinical Psychopharmacology, 2002
- Effects of Newer Antipsychotics on Extrapyramidal FunctionCNS Drugs, 2002
- Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysisBMJ, 2000
- Switching outpatients between atypical antipsychotics.Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2000
- Quetiapine, A Novel AntipsychoticPublished by Physicians Postgraduate Press, Inc ,1999
- Clozapine Withdrawal_Emergent Dystonias and DyskinesiasPublished by Physicians Postgraduate Press, Inc ,1998
- Multiple fixed doses of “Seroquel” (quetiapine) in patients with acute exacerbation of schizophrenia: A comparison with haloperidol and placeboBiological Psychiatry, 1997
- A Rating Scale for Drug-Induced AkathisiaThe British Journal of Psychiatry, 1989
- A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTSActa Psychiatrica Scandinavica, 1970